Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
siRNA
Biotech
Atalanta loads crossbow with $97M, 2 Big Pharmas in tow
Atalanta Therapeutics has bagged $97 million, funds that will go toward starting clinical trials for epilepsy and Huntington’s disease candidates.
Gabrielle Masson
Jan 28, 2025 7:00am
AI-powered Insitro taps Lilly to clear path to clinic for siRNA
Oct 9, 2024 9:28am
Silence breaks down phase 1 data on blood disorder prospect
Jun 27, 2024 9:40am
Silence loses Mallinckrodt collab, wins in cardiovascular ph. 2
Mar 13, 2024 8:54am
Boehringer bets $2B in biobucks on siRNA treatments for MASH
Jan 3, 2024 6:00am
ADARx preps 3rd clinical program and mulls IPO
Oct 3, 2023 10:55am